ARID1A is also one of the most frequently mutated genes in pancreatic adenocarcinoma [59] and in the PCAWG cohort, as 16/24 of tumours carried frameshift or stop-gain mutations that suggest loss of function. This evidence concerns the gene ARID1A and pancreatic adenocarcinoma.